메뉴 건너뛰기




Volumn 82, Issue 2, 2004, Pages 348-357

Evaluation of mixed protocols with Bravelle® (human-derived FSH) and Repronex® (hMG) to assess clinical efficacy (EMBRACE) in women undergoing in vitro fertilization

Author keywords

Bravelle; FSH; highly purified; hMG; human clinical trial; in vitro fertilization; LH; pregnancy; Repronex; subcutaneous; urofollitropin

Indexed keywords

ESTRADIOL; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; UROFOLLITROPIN;

EID: 4143153853     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2004.01.036     Document Type: Article
Times cited : (6)

References (25)
  • 1
    • 0002268642 scopus 로고
    • Synergism of the follicle stimulating and luteinizing hormones in producing estrogen secretion
    • Fevold H.L. Synergism of the follicle stimulating and luteinizing hormones in producing estrogen secretion. Endocrinology. 28:1941;33-36
    • (1941) Endocrinology , vol.28 , pp. 33-36
    • Fevold, H.L.1
  • 2
    • 84961043473 scopus 로고
    • Clinical effect of human pituitary follicle-stimulating hormone (FSH)
    • Gemzell C.A., Diczfalusy E., Tillinger G. Clinical effect of human pituitary follicle-stimulating hormone (FSH). J Clinical Endocrin Metab. 18:1958;1333-1348
    • (1958) J Clinical Endocrin Metab , vol.18 , pp. 1333-1348
    • Gemzell, C.A.1    Diczfalusy, E.2    Tillinger, G.3
  • 3
    • 0000140415 scopus 로고
    • L'induction de l'ovulation dans les aménorrhées hypophysaires par un traitement combiné de gonadotrophines urinaires ménopausiques et de gonadotrophines chorioniques
    • Lunenfeld B., Sulimovici S., Rabau E., Eshkol A. L'induction de l'ovulation dans les aménorrhées hypophysaires par un traitement combiné de gonadotrophines urinaires ménopausiques et de gonadotrophines chorioniques. Soc Fr Gynecol. 5:1962;346-351
    • (1962) Soc Fr Gynecol , vol.5 , pp. 346-351
    • Lunenfeld, B.1    Sulimovici, S.2    Rabau, E.3    Eshkol, A.4
  • 4
    • 0036843247 scopus 로고    scopus 로고
    • Assisted reproductive technology in the United States: 1999 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry
    • Society for Assisted Reproductive Technology and the American Society for Reproductive Medicine. Assisted reproductive technology in the United States 1999 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril. 78:2002;918-931
    • (2002) Fertil Steril , vol.78 , pp. 918-931
  • 5
    • 0033946336 scopus 로고    scopus 로고
    • Subcutaneously administered Repronex in female subjects undergoing in vitro fertilization is as effective and well tolerated as intramuscular menotropin treatment
    • Gocial B., Keye W.R., Fein S.H., Nardi R.V. the Repronex SC, IVF Study Group. Subcutaneously administered Repronex in female subjects undergoing in vitro fertilization is as effective and well tolerated as intramuscular menotropin treatment. Fertil Steril. 74:2000;73-79
    • (2000) Fertil Steril , vol.74 , pp. 73-79
    • Gocial, B.1    Keye, W.R.2    Fein, S.H.3    Nardi, R.V.4
  • 6
    • 0034950059 scopus 로고    scopus 로고
    • Subcutaneously administered Repronex in oligo-ovulatory female patients undergoing ovulation induction is as effective and well tolerated as intramuscular human menopausal gonadotropin treatment
    • Nichols J., Knochenhauer E., Fein S.H., Nardi R.V., Marshall D.C. Repronex SC Ovulation Induction Study Group. Subcutaneously administered Repronex in oligo-ovulatory female patients undergoing ovulation induction is as effective and well tolerated as intramuscular human menopausal gonadotropin treatment. Fertil Steril. 76:2001;58-66
    • (2001) Fertil Steril , vol.76 , pp. 58-66
    • Nichols, J.1    Knochenhauer, E.2    Fein, S.H.3    Nardi, R.V.4    Marshall, D.C.5
  • 7
    • 0036282998 scopus 로고    scopus 로고
    • Comparison of the efficacy and safety of a highly purified human follicle-stimulating hormone (Bravelle) and recombinant follitropin-β for in vitro fertilization: A prospective, randomized study
    • Dickey R., Thornton M., Nichols J., Marshall D., Fein S., Nardi R. Bravelle IVF Study Group. Comparison of the efficacy and safety of a highly purified human follicle-stimulating hormone (Bravelle) and recombinant follitropin-β for in vitro fertilization a prospective, randomized study. Fertil Steril. 77:2002;1202-1208
    • (2002) Fertil Steril , vol.77 , pp. 1202-1208
    • Dickey, R.1    Thornton, M.2    Nichols, J.3    Marshall, D.4    Fein, S.5    Nardi, R.6
  • 8
    • 0013920536 scopus 로고
    • Purification and separation of follicle stimulating hormone (FSH) and luteinizing hormone (LH) from human postmenopausal gonadotropin (HMG). II. Preparation of biological apparently pure FSH by selective binding of the LH with an anti-HCG serum and subsequent chromatography
    • Donini P., Puzzuoli D., D'Alessio I., Lunenfeld B., Eshkol A., Parlow A.F. Purification and separation of follicle stimulating hormone (FSH) and luteinizing hormone (LH) from human postmenopausal gonadotropin (HMG). II. Preparation of biological apparently pure FSH by selective binding of the LH with an anti-HCG serum and subsequent chromatography. Acta Endocrinol (Copenh). 52:1966;186-198
    • (1966) Acta Endocrinol (Copenh) , vol.52 , pp. 186-198
    • Donini, P.1    Puzzuoli, D.2    D'Alessio, I.3    Lunenfeld, B.4    Eshkol, A.5    Parlow, A.F.6
  • 9
    • 0002789193 scopus 로고
    • Pharmacokinetics of natural/recombinant FSH (follitropin) and some analogs
    • M. Filicori, & C. Flamigni. Amsterdam: Excerpta Medica
    • Sairam M., Sebok K. Pharmacokinetics of natural/recombinant FSH (follitropin) and some analogs. Filicori M., Flamigni C. Ovulation induction basic science and clinical advances. 1994;199-208 Excerpta Medica, Amsterdam
    • (1994) Ovulation Induction: Basic Science and Clinical Advances , pp. 199-208
    • Sairam, M.1    Sebok, K.2
  • 10
    • 0028069269 scopus 로고
    • Circulating bioactive and immunoreactive recombinant human follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects
    • Matikainen T., De Leeuw R., Mannaerts B., Huhtaniemi I. Circulating bioactive and immunoreactive recombinant human follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects. Fertil Steril. 61:1994;62-69
    • (1994) Fertil Steril , vol.61 , pp. 62-69
    • Matikainen, T.1    De Leeuw, R.2    Mannaerts, B.3    Huhtaniemi, I.4
  • 11
    • 0037323717 scopus 로고    scopus 로고
    • Meta-analysis of recombinant versus urinary-derived FSH: An update
    • Al-Inany H., Aboulgar M., Mansour R., Serour G. Meta-analysis of recombinant versus urinary-derived FSH an update. Hum Reprod. 18:2003;305-313
    • (2003) Hum Reprod , vol.18 , pp. 305-313
    • Al-Inany, H.1    Aboulgar, M.2    Mansour, R.3    Serour, G.4
  • 12
    • 0023712133 scopus 로고
    • Influence of serum luteinizing hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome
    • Homburg R., Armar N.A., Eshel A., Adams J., Jacobs H.S. Influence of serum luteinizing hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ. 297:1988;1024-1026
    • (1988) BMJ , vol.297 , pp. 1024-1026
    • Homburg, R.1    Armar, N.A.2    Eshel, A.3    Adams, J.4    Jacobs, H.S.5
  • 13
    • 0023879442 scopus 로고
    • Polycystic ovaries: A common finding in normal women
    • Polson D.W., Wadsworth J., Adams J., Franks S. Polycystic ovaries a common finding in normal women. Lancet. 1:1988;870-872
    • (1988) Lancet , vol.1 , pp. 870-872
    • Polson, D.W.1    Wadsworth, J.2    Adams, J.3    Franks, S.4
  • 14
    • 0030778063 scopus 로고    scopus 로고
    • Recombinant human follicle simulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP) results of a randomized comparative study in women undergoing assisted reproductive techniques
    • Bergh C., Howles C.M., Borg K., Hamberger L., Josefsson B., Nilsson L., Wikland M. Recombinant human follicle simulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP) results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod. 12:1997;2133-2139
    • (1997) Hum Reprod , vol.12 , pp. 2133-2139
    • Bergh, C.1    Howles, C.M.2    Borg, K.3    Hamberger, L.4    Josefsson, B.5    Nilsson, L.6    Wikland, M.7
  • 15
    • 0029089409 scopus 로고
    • Comparison of efficacy of high-dose pure follicle-stimulating hormone versus human menopausal gonadotropins for in vitro fertilization
    • Check J.H., O'Shaughnessy A., Nazari A., Hoover L. Comparison of efficacy of high-dose pure follicle-stimulating hormone versus human menopausal gonadotropins for in vitro fertilization. Gynecol Obstet Invest. 40:1995;117-119
    • (1995) Gynecol Obstet Invest , vol.40 , pp. 117-119
    • Check, J.H.1    O'Shaughnessy, A.2    Nazari, A.3    Hoover, L.4
  • 17
    • 0023681378 scopus 로고
    • Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: A randomized prospective study
    • Lavy G., Pellicer A., Diamond M.P., De Cherney A. Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone a randomized prospective study. Fertil Steril. 50:1988;74-78
    • (1988) Fertil Steril , vol.50 , pp. 74-78
    • Lavy, G.1    Pellicer, A.2    Diamond, M.P.3    De Cherney, A.4
  • 18
    • 0023182249 scopus 로고
    • Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropins for ovarian stimulation in an in vitro fertilization program
    • Scoccia B., Blumenthal P., Wagner C. Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropins for ovarian stimulation in an in vitro fertilization program. Fertil Steril. 48:1987;446-449
    • (1987) Fertil Steril , vol.48 , pp. 446-449
    • Scoccia, B.1    Blumenthal, P.2    Wagner, C.3
  • 19
    • 0022886579 scopus 로고
    • Use of hMG and/or FSH for multiple follicle development
    • Rosenwaks Z., Muasher S.J., Acosta A.A. Use of hMG and/or FSH for multiple follicle development. Clin Obstet Gynecol. 29:1986;148-166
    • (1986) Clin Obstet Gynecol , vol.29 , pp. 148-166
    • Rosenwaks, Z.1    Muasher, S.J.2    Acosta, A.A.3
  • 20
    • 0021907202 scopus 로고
    • Severe ovarian hyperstimulation syndrome from treatment with urinary follicle stimulating hormone: Two cases
    • Check J.H., Wu C.H., Gocial B., Adelson H.G. Severe ovarian hyperstimulation syndrome from treatment with urinary follicle stimulating hormone two cases. Fertil Steril. 43:1985;317-319
    • (1985) Fertil Steril , vol.43 , pp. 317-319
    • Check, J.H.1    Wu, C.H.2    Gocial, B.3    Adelson, H.G.4
  • 21
    • 0035178433 scopus 로고    scopus 로고
    • Mixed-protocol, same-syringe combination of gonadotropins: Compatibility of new, highly purified, human-derived FSH (Bravelle) and hMG (Repronex)
    • Marshall D.C., Raike E., De Silva M., Nardi R.V. Mixed-protocol, same-syringe combination of gonadotropins compatibility of new, highly purified, human-derived FSH (Bravelle) and hMG (Repronex). Today's Ther Trend. 19:2001;213-224
    • (2001) Today's Ther Trend , vol.19 , pp. 213-224
    • Marshall, D.C.1    Raike, E.2    De Silva, M.3    Nardi, R.V.4
  • 23
    • 0031876037 scopus 로고    scopus 로고
    • Glycoform composition of serum gonadotrophins through the normal menstrual cycle and in the post-menopausal state
    • Anobile C., Talbot J., McCann S., Padmanabhan V., Robertson W. Glycoform composition of serum gonadotrophins through the normal menstrual cycle and in the post-menopausal state. Mol Hum Reprod. 4:1998;631-639
    • (1998) Mol Hum Reprod , vol.4 , pp. 631-639
    • Anobile, C.1    Talbot, J.2    McCann, S.3    Padmanabhan, V.4    Robertson, W.5
  • 24
    • 0037323670 scopus 로고    scopus 로고
    • Clinical evidence for an LH "ceiling" effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation
    • Loumaye E., Engrand P., Shoham Z., Hillier S., Baird D.T. Recombinant LH Study Group. Clinical evidence for an LH "ceiling" effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation. Hum Reprod. 18:2003;314-322
    • (2003) Hum Reprod , vol.18 , pp. 314-322
    • Loumaye, E.1    Engrand, P.2    Shoham, Z.3    Hillier, S.4    Baird, D.T.5
  • 25
    • 0037307319 scopus 로고    scopus 로고
    • Profound luteinizing hormone suppression induces a deleterious follicular environment during assisted reproductive technology
    • Coppola F., Poti E.R., Barusi L., Ferrari B., Ssalvarani M.C., Vadora E. Profound luteinizing hormone suppression induces a deleterious follicular environment during assisted reproductive technology. Fertil Steril. 79:2003;459-460
    • (2003) Fertil Steril , vol.79 , pp. 459-460
    • Coppola, F.1    Poti, E.R.2    Barusi, L.3    Ferrari, B.4    Ssalvarani, M.C.5    Vadora, E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.